SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001144204-19-025615
Filing Date
2019-05-13
Accepted
2019-05-13 16:07:32
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tv521271_f3.htm F-3 232374
2 EXHIBIT 4.2 tv521271_ex4-2.htm EX-4.2 1643
3 EXHIBIT 5.1 tv521271_ex5-1.htm EX-5.1 14415
4 EXHIBIT 23.1 tv521271_ex23-1.htm EX-23.1 2822
5 GRAPHIC tv521271_img01.jpg GRAPHIC 8372
6 GRAPHIC image_001.jpg GRAPHIC 5588
7 GRAPHIC tv521271ex4-2x001.jpg GRAPHIC 174270
  Complete submission text file 0001144204-19-025615.txt   511987
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-231417 | Film No.: 19818441
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1